Minimize
Synexus Clinical Research SA offers a network of self-founded hubs and affiliated investigator sites for Phase 2 - 4 studies in South Africa
Synexus Clinical Research SA offers a network of self-founded hubs and affiliated investigator sites for Phase 2 - 4 studies in South Africa

Print  
 Fact Sheet: Clinical Research in South AfricaMinimize
  • South Africa ranks 10th in contribution to clinical trials in the world
  • South Africa maintains high standards of clinical practice
  • South Africa has a large, diverse patient base with a variety of pathology and infectious diseases
  • The pass rate of site audits by multinational companies and FDA in South Africa is high in comparison to overall industry standards
  • Guidelines for clinical trials in South Africa are stringent
  • Guidelines comply with both ICH and local Health Regulatory and Ethical review policies
  • South Africa has an extensive multi-disciplinary network of experienced and competent investigators
  • All investigators are trained in Good Clinical Priactices (GCP) as it is a requirement by the Regulatory Authority before participating in clinical trials
  • Extensive Phase II-IV clinical trial experience in most therapeutic areas. This includes hypertension, diabetes, arthritis, asthma, hyperlipidaemia and diverse acute and chronic infections
  • In the Sciences, English is the preferred language in South Africa
  • South African studies cost relatively less than in other developed countries (favourable exchange rate)
  • The value of clinical research in South Africa was estimated at US $200 million (approx. ZAR1.5 billion) in 2006
  • South Africa boasts a broad spectrum of cultural diversity (47.6 million residents) that is ideal of inter-ethnic comparisons
  • South Africa entertains a two tiered healthcare system, with clinical trial experience widely practiced through both public and private sectors
  • South African Public Sector - relatively easy access to patients
    • 369 general and 54 specialised state hospitals in 2003
    • Over 3000 primary healthcare centers (clinics, especially in rural areas)
    • Most of the population (>80%) depends on the State for medical services
    • Academic centers of excellence at the country's 7 medical schools (universities)
  • South African Private Sector - Access to patients possible
    • Approximately 18% (8 million) have private medical aid
    • State of the art diagnostic equipment in tertiary facilities
    • 343 Private hospitals in 2003
    • Several Mining and Military hospitals are also active in clinical trials
  • The southern hemisphere has reverse seasons to the northern hemisphere, placing it ideal for seasonal allergy/infection studies
  • Excellent telecommunication with a stable economy and established infrastructure
  • Current legislation is tolerant of pre-patent expiry bio-equivalence testing of generic medicines
  • Treatment-naive patients are readily available in sufficient number for a host of clinical conditions   

 REFERENCES:

  • Dept of Health website (www.doh.gov.za)

  • Business Briefings: Pharmagenerics, Sept 2003
  • Statistics SA: Mid-year population estimates, South Africa 2006

     


Print